Clinical Trial Update: Stelara fOr ChRonic AntibioTic rEfractory pouchitiS [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ustekinumab (Stelara) for chronic antibiotic-refractory pouchitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pouchitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Universitaire Ziekenhuizen KU Leuven | Conditions: Pouchitis | Phase 3 | Status: COMPLETED